479 related articles for article (PubMed ID: 11108873)
1. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
5. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in women receiving estrogen-progestin replacement therapy.
Persson I
Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
[TBL] [Abstract][Full Text] [Related]
7. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?
Ursin G; Tseng CC; Paganini-Hill A; Enger S; Wan PC; Formenti S; Pike MC; Ross RK
J Clin Oncol; 2002 Feb; 20(3):699-706. PubMed ID: 11821451
[TBL] [Abstract][Full Text] [Related]
8. Are progestins really necessary as part of a combined HRT regimen?
Sturdee DW
Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
10. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
12. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
13. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
Williams DB; Moley KH
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
[TBL] [Abstract][Full Text] [Related]
14. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
Archer DF
Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
[TBL] [Abstract][Full Text] [Related]
15. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
17. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
Gompel A
Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
[TBL] [Abstract][Full Text] [Related]
18. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
19. Estrogen with interrupted progestin HRT: a review of experimental and clinical studies.
Casper RF
Maturitas; 2000 Feb; 34(2):97-108. PubMed ID: 10714903
[TBL] [Abstract][Full Text] [Related]
20. Estrogens, progestins, and risk of breast cancer.
Pike MC; Wu AH; Spicer DV; Lee S; Pearce CL
Ernst Schering Found Symp Proc; 2007; (1):127-50. PubMed ID: 18540571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
